HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.

AbstractCONTEXT.—:
Somatic mutations in SMARCA4 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4) gene and/or BRG1 (Brahma-related gene 1) loss identifies a subset of non-small cell lung carcinomas (NSCLCs) lacking alterations in EGFR (epidermal growth factor receptor), ALK (anaplastic lymphoma kinase), and ROS1 (ROS proto-oncogene 1) genes. Preliminary observations suggest responsiveness to immunotherapy and targeted therapies.
OBJECTIVE.—:
To study BRG1 loss in NSCLCs and elucidate the clinicopathologic profile of such SMARCA4-deficient NSCLCs.
DESIGN.—:
Non-small cell lung carcinomas diagnosed during 6 years were subject to immunohistochemistry for BRG1 and BRM (Brahma). Tumors with BRG1 loss were stained with antibodies against thyroid transcription factor 1 (TTF-1), p40, cytokeratins, hepatocyte paraffin 1 (Hep Par 1), Sal-like protein 4 (SALL4), CD34, SRY-box 2 (SOX2), chromogranin, synaptophysin, p53, integrase interactor 1, ALK, and ROS1. EGFR mutation testing was performed by polymerase chain reaction-based method.
RESULTS.—:
Among 100 NSCLCs tested, 4 cases (4%) showed BRG1 loss. The histology ranged from solid adenocarcinomas (n = 1) to large cell/poorly differentiated carcinomas (n = 3) with clear cell cytology in 2 cases. All showed loss/reduction of BRM with variable cytokeratin and SALL4 expression, and were negative for TTF-1, p40, Hep Par 1, ALK, ROS1, and EGFR mutations. CD34 and SOX2 were negative in all 4 cases. Isolated BRM loss was common (21%), distributed across all NSCLC subtypes including squamous cell carcinomas and a hepatoid adenocarcinoma.
CONCLUSIONS.—:
BRG1 loss occurs in a subset of TTF-1/p40-negative poorly differentiated NSCLCs. Identification and follow-up will clarify the prognosis, diagnostic criteria, and potential for therapeutic personalization.
AuthorsAruna Nambirajan, Varsha Singh, Nishu Bhardwaj, Saurabh Mittal, Sunil Kumar, Deepali Jain
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 145 Issue 1 Pg. 90-98 (01 01 2021) ISSN: 1543-2165 [Electronic] United States
PMID33367658 (Publication Type: Journal Article, Review)
Copyright© 2021 College of American Pathologists.
Chemical References
  • MAS1 protein, human
  • Nuclear Proteins
  • Proto-Oncogene Mas
  • Transcription Factors
  • SMARCA4 protein, human
  • DNA Helicases
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Non-Small-Cell Lung (genetics, metabolism, pathology)
  • DNA Helicases (deficiency, genetics)
  • Humans
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Male
  • Middle Aged
  • Nuclear Proteins (deficiency, genetics)
  • Proto-Oncogene Mas
  • Retrospective Studies
  • Transcription Factors (deficiency, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: